Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Lupus Anticoagulant Syndrome is a subcategory of Antiphospholipid Syndrome (APS), an autoimmune condition characterized by the presence of specific antibodies that increase the risk of blood clots and pregnancy complications. This condition requires specialized blood tests to accurately diagnose and assess the associated thrombotic risk.
This comprehensive test measures three types of cardiolipin antibodies (IgA, IgG, and IgM) that are frequently present in Lupus Anticoagulant Syndrome. The presence of these antibodies significantly increases the risk of venous and arterial thrombosis, as well as pregnancy-related complications such as recurrent miscarriages and preeclampsia. Testing for all three antibody types provides a complete assessment for diagnostic purposes.
The diagnosis of Lupus Anticoagulant Syndrome relies on detecting specific antiphospholipid antibodies in the blood. These antibodies can interfere with normal blood clotting mechanisms, paradoxically increasing the risk of thrombosis despite their anticoagulant name. Laboratory testing is essential for confirming the presence of these antibodies and establishing the diagnosis.
Positive results for cardiolipin antibodies, particularly when persistent on repeat testing, support the diagnosis of Lupus Anticoagulant Syndrome. The presence of these antibodies helps healthcare providers assess thrombotic risk and determine appropriate treatment strategies, which may include anticoagulation therapy to prevent blood clots.
The information here is for educational purposes only and is not a substitute for professional medical advice. Diagnosis of Lupus Anticoagulant Syndrome typically requires multiple tests and clinical correlation. Always consult with a healthcare provider for proper diagnosis and treatment.